Pharmacology
New pharmacology in children research from Schering Plough Research Institute described
Published in Biotech Business Week, May 28th, 2007
Scientists discuss in "Pharmacokinetics of desloratadine in children between 2 and 11 years of age" new findings in pharmacology. According to a study from the United States, "The aim of the studies was to characterize the pharmacokinetics of desloratadine in healthy children and to determine the appropriate dose for paediatric patients 2-11 years old. Two open-label, single-dose studies were carried out in healthy children between 2-5 (n=18) and 6-11 years old (n=18)."
"On day 1, subjects received a single oral dose of desloratadine syrup (1.25 mg for 2-5 year olds or 2.5 mg for 6-11 year olds). Subjects were followed for an additional 4 days during which vital signs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Arthritis
Counseling, Coping Skills Could Reduce Arthritis Disability - Asthma
Ulcerative colitis sufferers find UC quite disruptive to many aspects of daily life - Autoimmune Disease
Natural immune-control system may aid treatment of autoimmune disease and tissue rejection - Breast Cancer
Chemotherapy More Effective When Given Before Breast Cancer Surgery - Breast Cancer
Soy estrogens and breast cancer research reported - Cancer
Scientists Activate New Cancer Drug Using Light and Oxygen - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
